Spotlight On Israel: Market Challenges Stunting Biopharma Growth

Scrip investigates the big issues Israel's biopharma sector need to overcome in order to maintain momentum and achieve sustainable success.

Aharon Aharon,CEO IsraelInnovationAuthority
Aharon Aharon, CEO of the Israel Innovation Authority • Source: Israel Innovation Authority

In its 70th anniversary year, Israel can rightly celebrate the boom in its high-tech sector over the last couple of decades. But while ICT companies lead the country's economy the Israeli government is set on promoting advancement in other high-tech fields, including biopharma – currently, a less developed industry.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business